These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1793164)

  • 1. Plasma protein C levels in children with sickle cell disease.
    Lane PA
    Am J Pediatr Hematol Oncol; 1991; 13(3):365-6. PubMed ID: 1793164
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced protein C levels--a contributory factor for stroke in sickle cell disease.
    Khanduri U; Gravell D; Christie BS; Al Lamki Z; Zachariah M; Cherian E
    Thromb Haemost; 1998 Apr; 79(4):879-80. PubMed ID: 9569210
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced thrombin generation in children with sickle cell disease.
    Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
    Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome.
    Onyemelukwe GC; Jibril HB
    Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein C levels in children with sickle cell disease.
    Karayalcin G; Lanzkowsky P
    Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C activity in Gabonese children with sickle cell disease.
    Blavy G; Gnansounou F; NGou-Milama E
    Nouv Rev Fr Hematol (1978); 1995; 37(4):251-2. PubMed ID: 8904207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III deficiency in Nigerian sicklers--possible predisposition to thrombotic crises.
    Onyemelukwe GC; Mba EC
    East Afr Med J; 1984 Jul; 61(7):565-9. PubMed ID: 6545202
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
    Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein C and antithrombin III in patients with acute leukemia.
    Cucuianu A; Brudaşcă I; Colhon D; Paţiu M; Basarab C; Cucuianu M
    Rom J Intern Med; 1994; 32(3):209-14. PubMed ID: 7866337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased protein S activity in sickle cell disease.
    Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation and physiological anticoagulants in sickle-cell disease.
    Bashawri LA; Al-Mulhim AA; Ahmed MA; Bahnassi AA
    East Mediterr Health J; 2007; 13(2):266-72. PubMed ID: 17684847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria and sickle cell disease.
    De Paz FJ; Romero A; Diez D; Botella C; Torrus D; Moscardó C
    Haematologica; 2006 Dec; 91(12 Suppl):EIM03. PubMed ID: 17194669
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
    Amin MA; Amin AP; Kulkarni HR
    Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III and congenital hemolytic anemia].
    Giustolisi R; Musso R; Cacciola E
    Haematologica; 1990; 75 Suppl 2():54-63. PubMed ID: 2387552
    [No Abstract]   [Full Text] [Related]  

  • 16. [Levels of antithrombin III and proteins C in the newborn infant].
    Abad A; Marco Vera P; Mompel A; García Pérez A
    Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited prethrombotic disorders and infectious purpura.
    Westendorp RG; Reitsma PH; Bertina RM
    Thromb Haemost; 1996 Jun; 75(6):899-901. PubMed ID: 8822583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C and protein S activity in sickle cell disease and stroke.
    Tam DA
    J Child Neurol; 1997 Jan; 12(1):19-21. PubMed ID: 9010791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion.
    Guareschi G; Viganò D'Angelo S; Foresti V; Bandello F; D'Angelo A
    Haematologica; 1990; 75(5):483-4. PubMed ID: 2151449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.